A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT06854640
Blood Coagulation Disorders, Cardiovascular Diseases
Liège, Belgium
View Trial DetailsNCT Number: NCT02936232
The aim of this study is to construct multi-center sepsis registry that can be used for data warehousing and clinical research.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea
This registry prospectively enrolls adult patients with severe sepsis or septic shock in 21 tertiary hospital emergency departments.
Registered data can be used for quality control and clinical research to reduce sepsis-related mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 28-day
According to hospital discharge record review and telephone follow-up.
Time frame: 90-day
According to hospital discharge record review and telephone follow-up.
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Interested in participating?
Request InfoSeoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06854640
Blood Coagulation Disorders, Cardiovascular Diseases
Liège, Belgium
View Trial DetailsNCT07040202
Arbovirus Infections, Dengue
Kampong Speu, Cambodia
View Trial DetailsNCT07154615
Infections, Inflammation
Minneapolis, Minnesota, United States
View Trial DetailsNCT05634733
Disease Attributes, Emergencies
Baltimore, Maryland, United States
View Trial Details